3 Results for "

JDQ-443

" in MedChemExpress (MCE) Product Catalog:
Products (3)

3 Results for "JDQ-443" in MCE Product Catalog:

7
7 Cited Publications
Art. -Nr.: HY-139612
CAS. Nr.: 2653994-08-0
Reinheit:  98.71%
Synonyms: JDQ-443; NVP-JDQ443
Target:  

Ras PERK

Forschungsgebiete:  

Inflammation/Immunology Cancer

Opnurasib (JDQ-443) (NVP-JDQ443) is an orally active, potent, selective, and covalent KRAS G12C inhibitor. Opnurasib shows antitumor activity .
loading...
    loading...
Art. -Nr.: HY-139612A
CAS. Nr.: 2653994-10-4
Reinheit:  99.32%
Synonyms: (S)-JDQ-443; (S)-NVP-JDQ443
Target:  

Drug Isomer Ras PERK

Forschungsgebiete:  

Inflammation/Immunology Cancer

(S)-Opnurasib ((S)-JDQ-443; (S)-NVP-JDQ443) is an isomer of Opnurasib (HY-139612). Opnurasib is an orally active, potent, selective, and covalent KRAS G12C inhibitor (extracted from patent WO2021120890A1). Opnurasib shows antitumor activity .
loading...
    loading...
Art. -Nr.: HY-139612B
CAS. Nr.: 2653201-38-6
Synonyms: (Rac)-JDQ-443; (Rac)-NVP-JDQ443
Target:  

Drug Derivative Ras PERK

Forschungsgebiete:  

Cancer

(Rac)-Opnurasib ((Rac)-JDQ-443; (Rac)-NVP-JDQ443) is the levorotomer of Opnurasib (HY-139612). Opnurasib is an orally active, potent, selective, and covalent KRAS G12C inhibitor (extracted from patent WO2021120890A1). Opnurasib shows antitumor activity .
loading...
    loading...